These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3568689)

  • 21. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenylbutazone in the horse: a review.
    Tobin T; Chay S; Kamerling S; Woods WE; Weckman TJ; Blake JW; Lees P
    J Vet Pharmacol Ther; 1986 Mar; 9(1):1-25. PubMed ID: 3517382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of age on phenylbutazone pharmacokinetics, metabolism and plasma protein binding in goats.
    Eltom SE; Guard CL; Schwark WS
    J Vet Pharmacol Ther; 1993 Jun; 16(2):141-51. PubMed ID: 8345564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH.
    Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing.
    Williams RJ; Boudinot FD; Smith JA; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):371-5. PubMed ID: 2316912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population distributions of phenylbutazone and oxyphenbutazone after oral and i.v. dosing in horses.
    Chay S; Woods WE; Nugent TE; Weckman T; Houston T; Sprinkle F; Blake JW; Tobin T; Soma LR; Yocum J
    J Vet Pharmacol Ther; 1984 Dec; 7(4):265-76. PubMed ID: 6512917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous determination of phenylbutazone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Marunaka T; Shibata T; Minami Y; Umeno Y
    J Chromatogr; 1980 Sep; 183(3):331-8. PubMed ID: 7419650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of an endurance-like exercise on the disposition and detection time of phenylbutazone and dexamethasone in the horse: application to medication control.
    Authie EC; Garcia P; Popot MA; Toutain PL; Doucet M
    Equine Vet J; 2010 Apr; 42(3):240-7. PubMed ID: 20486981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of phenylbutazone residues in horse tissues with and without enzyme-hydrolysis by LC-MS/MS.
    Boison JO; Dowling T; Johnson R; Kinar J
    Drug Test Anal; 2016 May; 8(5-6):535-8. PubMed ID: 27443208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse.
    Foreman JH; Barange A; Lawrence LM; Hungerford LL
    J Vet Pharmacol Ther; 2008 Feb; 31(1):39-44. PubMed ID: 18177317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
    Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH
    Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.
    Sams RA; Gerken DF; Dyke TM; Reed SM; Ashcraft SM
    J Vet Pharmacol Ther; 1997 Oct; 20(5):355-61. PubMed ID: 9350255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
    Arifah AK; Lees P
    J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM; Maruhn D; Maul W; Förster D; Ritter W
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
    Cheng Z; McKeller Q; Nolan A
    J Vet Pharmacol Ther; 1998 Aug; 21(4):315-21. PubMed ID: 9731955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.